A new drug's ability to slow cognitive decline in Alzheimer's patients was welcomed by experts on Wednesday, but they also cautioned that improvements were relatively modest and that the medication can have major adverse effects.
Continue reading your article with a FrontPage News Subscription
Already a Subscriber? Sign In
VIEW SUBSCRIPTION OPTIONS
Support independent journalism by subscribing